Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


05.04.2021

2 Ann Neurol
1 BMC Neurosci
1 Int J Neurosci
1 J Biol Chem
1 J Neurol Neurosurg Psychiatry
4 Mov Disord
1 Nature
1 Neurobiol Dis
1 Neurology
1 Neuroscience


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. ROSEBRAUGH M, Voight EA, Moussa EM, Jameel F, et al
    Foslevodopa/foscarbidopa: a new subcutaneous treatment for Parkinson's disease.
    Ann Neurol. 2021 Mar 26. doi: 10.1002/ana.26073.
    PubMed         Abstract available

  2. ELIAS GJB, Boutet A, Joel SE, Germann J, et al
    Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy.
    Ann Neurol. 2021;89:426-443.
    PubMed         Abstract available


    BMC Neurosci

  3. CUI SS, Fu R, Du JJ, Lin YQ, et al
    Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease.
    BMC Neurosci. 2021;22:22.
    PubMed         Abstract available


    Int J Neurosci

  4. ZHANG DD, Zhang CY, Zhang YX, Cui HP, et al
    G-CSF reduces loss of dopaminergic neurons by inhibiting TNF-alpha and IL-1beta in mouse model of Parkinson's disease.
    Int J Neurosci. 2021 Mar 29:1-12. doi: 10.1080/00207454.2021.1910259.
    PubMed         Abstract available


    J Biol Chem

  5. GUINEY SJ, Adlard PA, Lei P, Mawal CH, et al
    Fibrillar alpha-synuclein toxicity depends on functional lysosomes.
    J Biol Chem. 2020;295:17497-17513.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  6. AKBAR U, McQueen RB, Bemski J, Carter J, et al
    Prognostic predictors relevant to end-of-life palliative care in Parkinson's disease and related disorders: a systematic review.
    J Neurol Neurosurg Psychiatry. 2021 Mar 31. pii: jnnp-2020-323939.
    PubMed         Abstract available


    Mov Disord

  7. SCHIESS M, Suescun J, Doursout MF, Adams C, et al
    Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease.
    Mov Disord. 2021 Mar 27. doi: 10.1002/mds.28582.
    PubMed         Abstract available

  8. KLUGER BM, Dolhun R, Sumrall M, Hall K, et al
    Palliative Care and Parkinson's Disease: Time to Move Beyond Cancer.
    Mov Disord. 2021 Mar 30. doi: 10.1002/mds.28556.
    PubMed        

  9. VISANJI NP, Lang AE
    Call the Plumber: Impaired Meningeal Lymphatic Drainage in Parkinson's Disease.
    Mov Disord. 2021 Mar 30. doi: 10.1002/mds.28590.
    PubMed        

  10. HELMICH RC, Van den Berg KRE, Panyakaew P, Cho HJ, et al
    Cerebello-Cortical Control of Tremor Rhythm and Amplitude in Parkinson's Disease.
    Mov Disord. 2021 Apr 1. doi: 10.1002/mds.28603.
    PubMed        


    Nature

  11. WIE J, Liu Z, Song H, Tropea TF, et al
    Author Correction: A growth-factor-activated lysosomal K(+) channel regulates Parkinson's pathology.
    Nature. 2021 Mar 31. pii: 10.1038/s41586-021-03438.
    PubMed        


    Neurobiol Dis

  12. FAUSTINI G, Longhena F, Bruno A, Bono F, et al
    Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
    Neurobiol Dis. 2020;138:104789.
    PubMed         Abstract available


    Neurology

  13. RABER J, Darweesh SKL, Savica R
    Physical Activity May Reduce Apolipoprotein E4-Associated Cognitive Decline in Parkinson Disease.
    Neurology. 2021 Mar 31. pii: WNL.0000000000011851.
    PubMed        


    Neuroscience

  14. GUO X, Tang L, Tang X
    Current developments in cell replacement therapy for parkinson's disease.
    Neuroscience. 2021 Mar 24. pii: S0306-4522(21)00155.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: